| First Author | Zheng C | Year | 2018 |
| Journal | Cell Mol Immunol | Volume | 15 |
| Issue | 3 | Pages | 260-271 |
| PubMed ID | 28065940 | Mgi Jnum | J:313237 |
| Mgi Id | MGI:6791785 | Doi | 10.1038/cmi.2016.57 |
| Citation | Zheng C, et al. (2018) CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-gamma production by CD4(+) T cells. Cell Mol Immunol 15(3):260-271 |
| abstractText | The T-cell-mediated immune response is implicated in many clinical hepatic injuries, such as autoimmune hepatitis and acute virus hepatitis. CD24 is widely expressed by different immune cells and plays an important role in the pathogenesis of many autoimmune diseases. However, the role of CD24 in T-cell-mediated liver injury has not been elucidated until now. Here we showed that CD24 deficiency protects mice from concanavalin A (ConA)-induced fulminant liver injury by reducing serum interferon-gamma (IFN-gamma) levels. CD24 expression by hepatic T cells was markedly increased following ConA challenge. Moreover, decreased IFN-gamma production by hepatic CD4(+) T cells in CD24-deficient mice was detected, which was correlated with downregulated phosphorylation of STAT1 in hepatic tissue. In vitro experiments also supported the conclusion that CD24 deficiency impaired IFN-gamma production by CD4(+) T cells following ConA, CD3/CD28 and phorbol myristate acetate/ionomycin stimulation. Our study suggests that CD24 deficiency confers hepatoprotection by decreasing CD4(+) T-cell-dependent IFN-gamma production in vivo, which suggests that CD24 might be a potential target molecule for reducing clinical hepatitis. |
